1-2 of 2
Hairong Xu
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Real-world outcomes of brexucabtagene autoleucel for relapsed or refractory mantle cell lymphoma: a CIBMTR analysis

Open Access
Nausheen Ahmed, Swetha Thiruvengadam, Mehdi Hamadani, Zhen-Huan Hu, Natalie S. Grover, Mazyar Shadman, Frederick L. Locke, James Gerson, Matthew J Frank, Lihua E Budde, Michael L Wang, Soyoung Kim, Matthew Bye, Mohamed A Kharfan-Dabaja, Craig S. Sauter, Peiman Hematti, Cameron J. Turtle, Sairah Ahmed, Amy Moskop, Brent R. Logan, Ana Nunes, David M. Dalton, Ioana Magdalena Kloos, Dr, Daniel Lee, Hairong Xu, Marcelo C. Pasquini, Alex F. Herrera
Journal: Blood Advances
Blood Adv bloodadvances.2024015014.
https://doi.org/10.1182/bloodadvances.2024015014
Published: 2025
Includes: Supplemental data
Journal Articles

Impact of vein-to-vein time in patients with R/R LBCL treated with axicabtagene ciloleucel

Open Access
Frederick L. Locke, Tanya Siddiqi, Caron A. Jacobson, Sarah Nikiforow, Sairah Ahmed, David B. Miklos, Yi Lin, Matthew A. Lunning, Brian T. Hill, Armin Ghobadi, Zhen-Huan Hu, Michael T. Hemmer, Michael J. Zoratti, Suresh Vunnum, Jonathan Tsang, Clare Spooner, Harry Smith, Christine Fu, Anik Patel, Harry Miao, Shilpa A. Shahani, Debbie L. Mirjah, Hairong Xu, Marcelo C. Pasquini
Journal: Blood Advances
Blood Adv (2025) 9 (11): 2663–2676.
https://doi.org/10.1182/bloodadvances.2024013656
Published: 2025
Includes: Supplemental data